Fundz

Taysha Gene Therapies reported raising $30 Million in an initial SEC Form D filing, from an offering of $30 Million

PUBLIC · TSHANov 07, 2022

Amount Raised

$30 Million

$30 Million sold, per SEC Form D (first sale Oct 21, 2022)

Round Type

Venture

DallasBiotechnology

Quick answer

Taysha Gene Therapies, Inc. raised $30 Million in a funding round, dated October 21, 2022. Taysha Gene Therapies, Inc. is based in Dallas, Texas, United States.

How much did Taysha Gene Therapies, Inc. raise?
Taysha Gene Therapies, Inc. raised $30 Million in a funding round on October 21, 2022.
What does Taysha Gene Therapies, Inc. do?
Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease.
Where is Taysha Gene Therapies, Inc. based and how big is it?
Taysha Gene Therapies, Inc. is based in Dallas, Texas, United States.
Who are the decision-makers at Taysha Gene Therapies, Inc?
Fundz holds 1 contact at Taysha Gene Therapies, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Taysha Gene Therapies, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Aqualung Therapeutics Corp. raised $1.5M (Series A) on December 5, 2022.
  • Rejoni raised $26M on December 5, 2022.
  • Bactobio raised $7.8M (Funding Round) on December 5, 2022.
  • Vaxxas raised $23M (Funding Round) on December 5, 2022.
  • Advicenne raised an undisclosed amount (Debt Financing) on December 5, 2022.
  • ABK Biomedical raised $28M on December 5, 2022.

Who to call at Taysha Gene Therapies, Inc., and when

A new round usually means Taysha Gene Therapies, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Taysha Gene Therapies, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Taysha Gene Therapies, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Taysha Gene Therapies, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Taysha Gene Therapies, Inc.

Location

3000 PEGASUS PARK DRIVE

Dallas, Texas, United States

About

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we hope to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for new cures—to dramatically improve patients’ lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Taysha Gene Therapies, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Taysha Gene Therapies, Inc.'s next move

See what Strategic adds

Taysha Gene Therapies, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.